evaluation of micronutrients in obese patients

Conditions: Nutritional Disorder

Summary: the aim of the study primarily was to investigate the value of zinc to copper ratio as possible biomarker of trace elements imbalance in morbidly obese subjects undergoing lsg. secondly to correlate zinc to copper ratio with lipocalin 2 (lcn2) with respect to anthropometric measurements and other metabolic biomarkers. prospective study will be carried out on 120 morbidly obese adult subjects with a body mass index (bmi) score above 40 along with presence of obesity-related comorbidity. investigations will be measured preoperative and 9 months postoperative after performing laparoscopic sleeve gastrectomy; for body mass index (bmi) and waist circumference. as well as for complete blood count and biochemical biomarkers as fasting blood glucose, lipid profile, serum iron and ferritin. serum ceruloplasmin, zn and cu levels, followed by calculation of zinc to copper ratio. crp, serum insulin, serum leptin and lipocalin-2 (lcn2) will be determined.

consort 2010 flow diagram materials and methods: recruitment morbidly obese subjects attending clinic at surgery department for laparoscopic sleeve gastrectomy alexandria university hospitals. pre-assignment details adult morbidly obese subjects were included age above 20 years, bmi above 40 suffering from comorbidities as hypertension, dm, dyslipidemia. assigned participants were clinically evaluated for comorbidities as hypertension, dm, dyslipidemia. as well as signs of nutritional deficiency as anemia, brittle nails. group information one group of participants eligible for laparoscopic sleeve gastrectomy were assigned according to their will to participate in study. period of evaluation: first visit: preoperative for clinical assessment of participants, determine bmi and waist circumference and withdrawal of serum blood sample second visit: within one month after surgery to make sure that no complication occurred after surgery. third visit: nine months postoperative for revaluation of participants, determine bmi and waist circumference, and withdrawal of a serum blood sample number of participants at initiating the period of study. they were 120 morbidly obese subjects. number of participants at the end of the period of study. they were 107 subjects, 13 obese subject withdraw from study as they didn't come during follow up period after 9 months. participants according sex (69 females, and 38 male), with the mean age of 41.6±8.9 years. the mean preoperative bmi was 47.43±5.4 kg/m2. then, they were evaluated 9 months after lsg. preoperative and postoperative clinical characteristics and metabolic variables in studied subjects. preoperative 9 months postoperative p body weight (kg) 129.7 ± 12.1 93.4 ±13.6 0.0013\* bmi (kg/m2) 47.43±5.4 35.7±3.8 0.0052\* waist circumference (cm) 130.00 ± 4.68 91.82 ± 3.73 0.001\* systolic bp (mmhg) 146.0±17.0 132.0±11.0 0.001\* total cholesterol (mmol/l) 5.85 ± 0.41 4.64 ± 0.31 0.035\* triglycerides (mmol/l) 2.20 ± 0.23 1.92 ± 0.24 0.106 hdl cholesterol (mmol/l) 1.23 ± 0.19 1.39 ± 0.2 0.041\* ldl cholesterol (mmol/l) 3.37 ± 0.23 2.97 ± 0.21 0.022\* homa-ir 2.64 ± 1.3 1.44 ± 0.81 0.013\* s. leptin (ng/ml) 102.87 ± 49.16 33.47 ±12.76 0.0001\* crp (mg/l) 8.4±5.91 3.2±2.98 0.001\* lipocalin 2 (µg/l) 107.24±36.8 51.6±12.73 0.001\* albumin (g/dl) 4.05±0.21 3.91±0.29 0.113 \*statistically significant at (p≤0.05). outcome measures: primarily was to investigate the value of zinc to copper ratio as possible biomarker of te imbalance in morbidly obese subjects undergoing lsg. for detection of presence of micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight secondly to correlate it with lipocalin 2 (lcn2) with respect to anthropometric measurements and other metabolic markers prospectively. as zinc to copper ratio is considered as biomarker of micronutrient status; therefore, correlate it with other biomarkers of inflammation (lipocalin 2) and other parameters as bmi, fbg to determine if micronutrient status improve after weight loss or not time frame: 9 months. follow-up and outcome parameters: all studied subjects will be followed up for early postoperative complications (within the first month) as bleeding or leak. then they will be reviewed after 9 months postoperatively for assessment of anthropometric measurements, control of preoperative comorbidities, and manifestations of te deficiencies (anemia, hair loss, teeth problems, edema. etc.). anthropometric parameters body mass index (bmi) and waist circumference will be measured preoperative and 9 months postoperative. biochemical parameters fasting blood samples will be collected from participants prior to surgery and nine months postoperative, after overnight fast and divided into two tubes; edta for complete blood count, the rest into plastic tubes and serum sample. serum glucose and total cholesterol, hdl- cholesterol, ldl- cholesterol, and triglyceride, total protein and albumin. serum iron (fe), and ferritin. serum insulin, ceruloplasmin, zn and cu levels, crp and lipocalin-2 (lcn2) . statistical analysis all data will be analyzed with statistical package for the social sciences version 20 software (spss, inc., chicago, il). results will be displayed as mean ± sd. paired student's t-test used to compare the data pre-operative and nine months postoperative. the chi-squared test used for category variables. spearman correlation coefficient used to detect the correlation between different variables. statistical correlations calculated by pearson's correlation test. p \< 0.05 is considered significant.

Eligibility criteria:
inclusion criteria: * micronutrient deficiency in morbid obese subjects adults. * bmi above 40 * presence of comorbidities as hypertenion, dm, dislipidemia exclusion criteria: * all causes which might cause micronutrient deficiency as presence of gastroesophageal reflux * all causes which may cause increase obesity "bmi" as hormonal disturbance ; hypothyroidism or cushing, females receiving contraceptive pills

Keywords: obesity zinc copper lipocalin 2